Abstract
Enterobacteria contribute to two serious clinical syndromes seen in African AIDS patients: diarrhea and septicemia. In West Africa, prophylaxis with sulfamethoxazole-trimethoprim (SXT) reduced illnesses. We report reduced sensitivity of enterobacteria to available antimicrobial agents in Zambia, with only 22% of nontyphoidal salmonellae and 6% of shigellae sensitive to SXT.
Publication types
-
Clinical Trial
-
Comparative Study
-
Controlled Clinical Trial
MeSH terms
-
Adult
-
Cyproterone Acetate / therapeutic use
-
Drug Combinations
-
Estradiol / analogs & derivatives*
-
Estradiol / therapeutic use
-
Female
-
Hormone Replacement Therapy / adverse effects*
-
Humans
-
Leiomyoma / chemically induced*
-
Leiomyoma / diagnostic imaging
-
Norgestrel / therapeutic use
-
Prospective Studies
-
Treatment Outcome
-
Ultrasonography
-
Uterine Hemorrhage / drug therapy
-
Uterine Neoplasms / chemically induced*
-
Uterine Neoplasms / diagnostic imaging
Substances
-
Drug Combinations
-
estradiol valerate, cyproterone acetate drug combination
-
Norgestrel
-
Cyproterone Acetate
-
Estradiol